The standout finding is the sub‑20th percentile forward P/E, which together with a low PEG signals that the market may be over‑discounting SCSC’s near‑term earnings acceleration, offering an attractive entry point for value‑oriented investors.
A valuation risk lies in the low P/E compression: if earnings growth stalls below the projected ~12% rate, the forward P/E could rebound toward historic averages, eroding the discount and potentially triggering a 10–15% price correction.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 6.6% (10Y CAGR) | Analyst Rev × 6.3% margin |
| PV of FCF | $502.6M | $868.7M |
| Terminal Value (PV) | $2.32B | $3.78B |
| Enterprise Value | $2.82B | $4.65B |
| Equity Value | $2.80B | $4.63B |
| Implied Stock Price | $137.48 | $226.85 |
| Upside/Downside | +189.8% | +378.2% |
| WACC \ Growth | 2.5% | 3.0% | 3.5% | 4.0% | 4.5% |
|---|---|---|---|---|---|
| 5.9% | $184 | $213 | $253 | $314 | $419 |
| 6.9% | $142 | $157 | $178 | $205 | $244 |
| 7.9% | $115 | $125 | $137 | $152 | $171 |
| 8.9% | $96 | $103 | $111 | $120 | $132 |
| 9.9% | $83 | $88 | $93 | $100 | $107 |
| WACC \ Growth | 2.5% | 3.0% | 3.5% | 4.0% | 4.5% |
|---|---|---|---|---|---|
| 5.9% | $303 | $349 | $415 | $514 | $685 |
| 6.9% | $234 | $259 | $292 | $337 | $400 |
| 7.9% | $190 | $206 | $226 | $250 | $282 |
| 8.9% | $160 | $171 | $184 | $199 | $218 |
| 9.9% | $138 | $146 | $155 | $165 | $178 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $92.65 | +95.3% | Peer median P/E (21.0x) × Forward EPS ($4.41) |
| P/B (Peer) | $137.35 | +189.5% | Peer median P/B (3.13x) × Book Value per Share |
| EV/EBITDA (Peer) | $70.75 | +49.1% | Peer median EV/EBITDA (12.7x) × EBITDA - Net Debt |
| P/S (Peer) | $206.58 | +335.5% | Peer median P/S (1.40x) × Revenue per Share |
| DCF | $137.48 | +189.8% | Revenue × FCF Margin projection |
| Analyst Target | $43.00 | -9.4% | Consensus of 3 analysts |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net